- Home
- BZFD vs IMUX Comparison
BZFD vs IMUX Comparison
Compare BZFD & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZFD
- IMUX
- Stock Information
- Founded
- BZFD 2006
- IMUX 2016
- Country
- BZFD United States
- IMUX United States
- Employees
- BZFD N/A
- IMUX N/A
- Industry
- BZFD Movies/Entertainment
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- BZFD Consumer Discretionary
- IMUX Health Care
- Exchange
- BZFD Nasdaq
- IMUX Nasdaq
- Market Cap
- BZFD 78.2M
- IMUX 67.8M
- IPO Year
- BZFD N/A
- IMUX N/A
- Fundamental
- Price
- BZFD $2.00
- IMUX $0.73
- Analyst Decision
- BZFD
- IMUX Strong Buy
- Analyst Count
- BZFD 0
- IMUX 6
- Target Price
- BZFD N/A
- IMUX $11.60
- AVG Volume (30 Days)
- BZFD 178.6K
- IMUX 2.5M
- Earning Date
- BZFD 08-11-2025
- IMUX 08-07-2025
- Dividend Yield
- BZFD N/A
- IMUX N/A
- EPS Growth
- BZFD N/A
- IMUX N/A
- EPS
- BZFD 0.34
- IMUX N/A
- Revenue
- BZFD $188,899,000.00
- IMUX N/A
- Revenue This Year
- BZFD $6.29
- IMUX N/A
- Revenue Next Year
- BZFD $6.16
- IMUX N/A
- P/E Ratio
- BZFD $6.15
- IMUX N/A
- Revenue Growth
- BZFD N/A
- IMUX N/A
- 52 Week Low
- BZFD $1.61
- IMUX $0.56
- 52 Week High
- BZFD $5.68
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- BZFD 50.27
- IMUX 41.51
- Support Level
- BZFD $1.95
- IMUX $0.68
- Resistance Level
- BZFD $2.15
- IMUX $0.74
- Average True Range (ATR)
- BZFD 0.08
- IMUX 0.06
- MACD
- BZFD -0.01
- IMUX 0.00
- Stochastic Oscillator
- BZFD 37.50
- IMUX 27.32
About BZFD BuzzFeed Inc.
BuzzFeed Inc is a tech-powered, diversified media company that reaches hundreds of millions globally through its cross-platform news and entertainment network. The company produces articles, lists, quizzes, videos, and original series; lifestyle content through brands including Tasty, social food network; original reporting and investigative journalism through BuzzFeed News and HuffPost; an industry- affiliate business, strategic partnerships, licensing and product development through BuzzFeed Commerce; and original productions across broadcast, cable, SVOD, film and digital platforms for BuzzFeed Studios.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.